Abstract
Dysferlinopathy, a rare type of limb-girdle muscular dystrophy (LGMDR2) caused by mutations in the DYSF gene, is characterised by a broad spectrum of muscle weakness and variable rates of disease progression. Observations have revealed that patients with LGMDR2 display a distinct gait pattern, however this has not yet been objectively quantified. Thus, clinically meaningful and validated outcomes are essential to accurately evaluate disease progression. The aim was to objectively quantify temporal-spatial characteristics of gait in patients with LGMDR2 and evaluate differences in gait when walking barefoot, in socks and shod.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
